POWER INVERTER AND METHOD FOR CONTROLLING A POWER INVERTER von KOHTAMAKI, Tuomo Matias, JEDD, Christopher

Volltext bestellen

POWER INVERTER AND METHOD FOR CONTROLLING A POWER INVERTER von KOHTAMAKI, Tuomo Matias, JEDD, Christopher

Volltext bestellen

POWER INVERTER AND METHOD FOR CONTROLLING A POWER INVERTER von KOHTAMAKI, Tuomo Matias, JEDD, Christopher

Volltext bestellen

Power inverter and method for controlling a power inverter von Christopher Jedd, Tuomo Matias Kohtamäki

Volltext bestellen

Clinical implications of T cell exhaustion for cancer immunotherapy von Chow, Andrew, Perica, Karlo, Klebanoff, Christopher A., Wolchok, Jedd D.

Volltext

Stereotactic Radiosurgery for Melanoma Brain Metastases in Patients Receiving Ipilimumab: Safety Profile and Efficacy of Combined Treatment von Kiess, Ana P., MD, PhD, Wolchok, Jedd D., MD, PhD, Barker, Christopher A., MD, Postow, Michael A., MD, Tabar, Viviane, MD, Huse, Jason T., MD, PhD, Chan, Timothy A., MD, PhD, Yamada, Yoshiya, MD, Beal, Kathryn, MD

Volltext

Genetic Basis for Clinical Response to CTLA-4 Blockade in Melanoma von Snyder, Alexandra, Makarov, Vladimir, Merghoub, Taha, Yuan, Jianda, Zaretsky, Jesse M, Desrichard, Alexis, Walsh, Logan A, Postow, Michael A, Wong, Phillip, Ho, Teresa S, Hollmann, Travis J, Bruggeman, Cameron, Kannan, Kasthuri, Li, Yanyun, Elipenahli, Ceyhan, Liu, Cailian, Harbison, Christopher T, Wang, Lisu, Ribas, Antoni, Wolchok, Jedd D, Chan, Timothy A

Volltext

Nivolumab plus ipilimumab or nivolumab alone versus ipilimumab alone in advanced melanoma (CheckMate 067): 4-year outcomes of a multicentre, randomised, phase 3 trial von Hodi, Frank Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Cowey, Charles Lance, Lao, Christopher D, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Hill, Andrew, Hogg, David, Marquez-Rodas, Ivan, Jiang, Joel, Rizzo, Jasmine, Larkin, James, Wolchok, Jedd D

Volltext

Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized... von Schadendorf, Dirk, Wolchok, Jedd D, Hodi, F Stephen, Chiarion-Sileni, Vanna, Gonzalez, Rene, Rutkowski, Piotr, Grob, Jean-Jacques, Cowey, C Lance, Lao, Christopher D, Chesney, Jason, Robert, Caroline, Grossmann, Kenneth, McDermott, David, Walker, Dana, Bhore, Rafia, Larkin, James, Postow, Michael A

Volltext

Long-Term Outcomes With Nivolumab Plus Ipilimumab or Nivolumab Alone Versus Ipilimumab in Patients With Advanced Melanoma von Wolchok, Jedd D, Chiarion-Sileni, Vanna, Gonzalez, Rene, Grob, Jean-Jacques, Rutkowski, Piotr, Lao, Christopher D, Cowey, C Lance, Schadendorf, Dirk, Wagstaff, John, Dummer, Reinhard, Ferrucci, Pier Francesco, Smylie, Michael, Butler, Marcus O, Hill, Andrew, Márquez-Rodas, Ivan, Haanen, John B A G, Guidoboni, Massimo, Maio, Michele, Schöffski, Patrick, Carlino, Matteo S, Lebbé, Céleste, McArthur, Grant, Ascierto, Paolo A, Daniels, Gregory A, Long, Georgina V, Bas, Tuba, Ritchings, Corey, Larkin, James, Hodi, F Stephen

Volltext

Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis von Kuk, Deborah, Shoushtari, Alexander N., Barker, Christopher A., Panageas, Katherine S., Munhoz, Rodrigo R., Momtaz, Parisa, Ariyan, Charlotte E., Brady, Mary Sue, Coit, Daniel G., Bogatch, Kita, Callahan, Margaret K., Wolchok, Jedd D., Carvajal, Richard D., Postow, Michael A.

Volltext

Preoperative CTLA-4 Blockade: Tolerability and Immune Monitoring in the Setting of a Presurgical Clinical Trial von CARTHON, Bradley C, WOLCHOK, Jedd D, SHARMA, Padmanee, JIANDA YUAN, KAMAT, Ashish, NG TANG, Derek S, JINGJING SUN, KU, Geoffrey, TRONCOSO, Patricia, LOGOTHETIS, Christopher J, ALLISON, James P

Volltext

Shared cancer neoantigens: Making private matters public von Klebanoff, Christopher A, Wolchok, Jedd D

Volltext

Phase II Study of Nilotinib in Melanoma Harboring KIT Alterations Following Progression to Prior KIT Inhibition von Carvajal, Richard D, Lawrence, Donald P, Weber, Jeffrey S, Gajewski, Thomas F, Gonzalez, Rene, Lutzky, Jose, O'Day, Steven J, Hamid, Omid, Wolchok, Jedd D, Chapman, Paul B, Sullivan, Ryan J, Teitcher, Jerrold B, Ramaiya, Nikhil, Giobbie-Hurder, Anita, Antonescu, Cristina R, Heinrich, Michael C, Bastian, Boris C, Corless, Christopher L, Fletcher, Jonathan A, Hodi, F Stephen

Volltext

Immunologic Correlates of the Abscopal Effect in a Patient with Melanoma von Postow, Michael A, Callahan, Margaret K, Barker, Christopher A, Yamada, Yoshiya, Yuan, Jianda, Kitano, Shigehisa, Mu, Zhenyu, Rasalan, Teresa, Adamow, Matthew, Ritter, Erika, Sedrak, Christine, Jungbluth, Achim A, Chua, Ramon, Yang, Arvin S, Roman, Ruth-Ann, Rosner, Samuel, Benson, Brenna, Allison, James P, Lesokhin, Alexander M, Gnjatic, Sacha, Wolchok, Jedd D

Volltext

Targeting Phosphatidylserine Enhances the Anti-tumor Response to Tumor-Directed Radiation Therapy in a Preclinical Model of Melanoma von Budhu, Sadna, Giese, Rachel, Gupta, Aditi, Fitzgerald, Kelly, Zappasodi, Roberta, Schad, Sara, Hirschhorn, Daniel, Campesato, Luis Felipe, De Henau, Olivier, Gigoux, Mathieu, Liu, Cailian, Mazo, Gregory, Deng, Liang, Barker, Christopher A., Wolchok, Jedd D., Merghoub, Taha

Volltext

Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma: A Randomized Clinical Trial von Carvajal, Richard D, Sosman, Jeffrey A, Quevedo, Jorge Fernando, Milhem, Mohammed M, Joshua, Anthony M, Kudchadkar, Ragini R, Linette, Gerald P, Gajewski, Thomas F, Lutzky, Jose, Lawson, David H, Lao, Christopher D, Flynn, Patrick J, Albertini, Mark R, Sato, Takami, Lewis, Karl, Doyle, Austin, Ancell, Kristin, Panageas, Katherine S, Bluth, Mark, Hedvat, Cyrus, Erinjeri, Joseph, Ambrosini, Grazia, Marr, Brian, Abramson, David H, Dickson, Mark Andrew, Wolchok, Jedd D, Chapman, Paul B, Schwartz, Gary K

Volltext

Robust Antitumor Responses Result from Local Chemotherapy and CTLA-4 Blockade von Ariyan, Charlotte E, Brady, Mary Sue, Siegelbaum, Robert H, Hu, Jian, Bello, Danielle M, Rand, Jamie, Fisher, Charles, Lefkowitz, Robert A, Panageas, Kathleen S, Pulitzer, Melissa, Vignali, Marissa, Emerson, Ryan, Tipton, Christopher, Robins, Harlan, Merghoub, Taha, Yuan, Jianda, Jungbluth, Achim, Blando, Jorge, Sharma, Padmanee, Rudensky, Alexander Y, Wolchok, Jedd D, Allison, James P

Volltext

The ectonucleotidase CD39 identifies tumor-reactive CD8+ T cells predictive of immune checkpoint blockade efficacy in human lung cancer von Chow, Andrew, Uddin, Fathema Z., Liu, Michael, Dobrin, Anton, Nabet, Barzin Y., Mangarin, Levi, Lavin, Yonit, Rizvi, Hira, Tischfield, Sam E., Quintanal-Villalonga, Alvaro, Chan, Joseph M., Shah, Nisargbhai, Allaj, Viola, Manoj, Parvathy, Mattar, Marissa, Meneses, Maximiliano, Landau, Rebecca, Ward, Mariana, Kulick, Amanda, Kwong, Charlene, Wierzbicki, Matthew, Yavner, Jessica, Egger, Jacklynn, Chavan, Shweta S., Farillas, Abigail, Holland, Aliya, Sridhar, Harsha, Ciampricotti, Metamia, Hirschhorn, Daniel, Guan, Xiangnan, Richards, Allison L., Heller, Glenn, Mansilla-Soto, Jorge, Sadelain, Michel, Klebanoff, Christopher A., Hellmann, Matthew D., Sen, Triparna, de Stanchina, Elisa, Wolchok, Jedd D., Merghoub, Taha, Rudin, Charles M.

Volltext

A Pilot Study of Preoperative Single-Dose Ipilimumab and/or Cryoablation in Women with Early-Stage Breast Cancer with Comprehensive Immune Profiling von McArthur, Heather L, Diab, Adi, Page, David B, Yuan, Jianda, Solomon, Stephen B, Sacchini, Virgilio, Comstock, Christopher, Durack, Jeremy C, Maybody, Majid, Sung, Janice, Ginsberg, Arielle, Wong, Phillip, Barlas, Afsar, Dong, Zhiwan, Zhao, Chunjun, Blum, Brian, Patil, Sujata, Neville, Deirdre, Comen, Elizabeth A, Morris, Elizabeth A, Kotin, Alan, Brogi, Edi, Wen, Y Hannah, Morrow, Monica, Lacouture, Mario E, Sharma, Padmanee, Allison, James P, Hudis, Clifford A, Wolchok, Jedd D, Norton, Larry

Volltext